0001127602-18-027528.txt : 20180913 0001127602-18-027528.hdr.sgml : 20180913 20180913184132 ACCESSION NUMBER: 0001127602-18-027528 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180913 FILED AS OF DATE: 20180913 DATE AS OF CHANGE: 20180913 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: McBride Daniel G CENTRAL INDEX KEY: 0001368867 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-08597 FILM NUMBER: 181069810 MAIL ADDRESS: STREET 1: 5 EL CORTE CITY: ORINDA STATE: CA ZIP: 94563 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: COOPER COMPANIES INC CENTRAL INDEX KEY: 0000711404 STANDARD INDUSTRIAL CLASSIFICATION: OPHTHALMIC GOODS [3851] IRS NUMBER: 942657368 STATE OF INCORPORATION: DE FISCAL YEAR END: 1031 BUSINESS ADDRESS: STREET 1: 6140 STONERIDGE MALL RD STREET 2: STE 590 CITY: PLEASANTON STATE: CA ZIP: 94588 BUSINESS PHONE: 9254603600 MAIL ADDRESS: STREET 1: 6140 STONERIDGE MALL ROAD STREET 2: SUITE 590 CITY: PLEASANTON STATE: CA ZIP: 94588 FORMER COMPANY: FORMER CONFORMED NAME: COOPERVISION INC DATE OF NAME CHANGE: 19870701 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2018-09-13 0000711404 COOPER COMPANIES INC COO 0001368867 McBride Daniel G THE COOPER COMPANIES, INC. 6140 STONERIDGE MALL ROAD, SUITE 590 PLEASANTON CA 94588 1 EVP, COO & Pres-CooperVision Common Stock 2018-09-13 4 M 0 10310 95.74 A 38705 D Common Stock 2018-09-13 4 S 0 4721 263.59 D 33984 D Common Stock 2018-09-13 4 S 0 2212 264.224 D 31772 D Common Stock 2018-09-13 4 S 0 3058 265.703 D 28714 D Common Stock 2018-09-13 4 S 0 319 266.504 D 28395 D Common Stock 2120 I 401(k) Plan Employee Stock Option (Right to Buy) 95.74 2018-09-13 4 M 0 10310 0 D 2022-12-11 Common Stock 10310 0 D The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $263.00 to $263.98. The reporting person undertakes to provide to The Cooper Companies, Inc., any security holder of The Cooper Companies, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the footnotes to this Form 4. The sales price represents a weighted average of sales prices ranging between $264.00 and $264.46. The sales price represents a weighted average of sales prices ranging between $265.26 and $266.09. The sales price represents a weighted average of sales prices ranging between $266.38 and $266.56. 12/12/12 NQ Grant: The options will vest in equal increments over five years measured from the date of grant as follows: 1/5 shall vest on 12/12/13; 1/5 shall vest on 12/12/14; 1/5 shall vest on 12/12/15; 1/5 shall vest on 12/12/16; and 1/5 shall vest on 12/12/17. /s/ Daniel G. McBride 2018-09-13